RCE 2.06% 49.5¢ recce pharmaceuticals ltd

Ann: Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort, page-4

  1. 409 Posts.
    lightbulb Created with Sketch. 60
    they are oblidged by ASX listing rules to maintain continuous disclosure to the market and its shareholders...

    given the low volume, I feel we have somewhat of stalemate currently where buyers aren't bidding high enough to satisfy the sellers. That's good

 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.